PI
Prolifagen, Inc.
SEC filingBiotechnology · Doylestown, PA
Amount raised$3Msold at filing
Total offeringNot stated
Investors in the raise6count reported to the SEC
FiledSep 23, 2025first sale Sep 2, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
M. Alexander ShawDirector
Andreas Alexander BaderExecutive Officer
William Alexander HoustonExecutive Officer
Michael BehrExecutive Officer, Director
Claudine BruckExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.